Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
8
|
pubmed:dateCreated |
1994-11-4
|
pubmed:abstractText |
The clinical value of a newly developed renography agent 99mTc-mercaptoacetylglycylglycylglycine (99mTc-MAG3) was assessed in comparison with 123I-orthoiodohippurate (123I-OIH). A clear perfusion images were obtained early after 99mTc-MAG3 administration due to physical advantages of the tracer. A close correlation was observed of Tmax and T1/2 values between 99mTc-MAG3 and 123I-OIH. However, T1/2 calculated by 99mTc-MAG3 was significantly longer than that by 123I-OIH. In addition, the effective renal plasma flow (ERPF) value calculated by the clearance rate of the tracer by Tauxe method (radioactivity in plasma at 43 minutes after tracer administration) was smaller than that by 123I-OIH. In conclusion, 99mTc-MAG3 is considered as a useful agent for renography.
|
pubmed:language |
jpn
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Aug
|
pubmed:issn |
0022-7854
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
31
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
977-83
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:7933686-Female,
pubmed-meshheading:7933686-Humans,
pubmed-meshheading:7933686-Iodine Radioisotopes,
pubmed-meshheading:7933686-Iodohippuric Acid,
pubmed-meshheading:7933686-Kidney,
pubmed-meshheading:7933686-Kidney Function Tests,
pubmed-meshheading:7933686-Middle Aged,
pubmed-meshheading:7933686-Predictive Value of Tests,
pubmed-meshheading:7933686-Radioisotope Renography,
pubmed-meshheading:7933686-Technetium Tc 99m Mertiatide
|
pubmed:year |
1994
|
pubmed:articleTitle |
[Usefulness of renal dynamic function study with 99mTc-MAG3 (mercaptoacetylglycylglycylglycine)].
|
pubmed:affiliation |
Department of Radiology, Kyoto University Faculty of Medicine.
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Comparative Study,
English Abstract,
Case Reports,
Controlled Clinical Trial,
Clinical Trial, Phase III
|